Company Profiles

driven by the PitchBook Platform

Immunethep

Immunethep
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
2 INVESTORS
Description

Developer of anti-bacterial immunotherapies. The company develops neonatal vaccines to protect neonates from bacterial infections inside mother's womb.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Primary Office
Biocant Park - NĂșcleo 04 Lote 3
Cantanhede, 3060-197
Portugal
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Immunethep’s full profile, request a free trial.

Immunethep Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 13-Apr-2015 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Immunethep Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Portugal Capital Ventures Venture Capital Minority 000 0000 000000 0
Venture Catalysts Accelerator/Incubator Minority 000 0000 000000 0

Immunethep Executive Team (4)

Name Title Board
Seat
Contact
Info
Pedro Madureira Ph.D Chief Scientific Officer & Co-Founder
Bruno Santos Chief Executive Officer & Co-Founder
Hugo Ramos Co-Founder
Rafael Simao Co-Founder